Allergan plc (AGN)

NYSE - NYSE Real Time Price. Currency in USD
239.36+0.68 (+0.28%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close238.68
Bid238.39 x 100
Ask255.00 x 200
Day's Range237.50 - 240.80
52wk Range195.50 - 322.68
1y Target EstN/A
Market Cap94.78B
P/E Ratio (ttm)22.79
Avg Vol (3m)3,043,035
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswire18 hours ago

    Orange County Business Council Study Showcases Economic Impact of Allergan on California Economy

    IRVINE, Calif., Sept. 27, 2016 /PRNewswire/ -- A new study conducted by the Orange County Business Council (OCBC) found that Allergan's California operations generated a combined annual economic activity in the state of approximately $6.35 billion and net economic impact of $3.45 billion. The economic impact is a direct result of the Company's strong influence on employment in the state, generating more than 16,600 direct, indirect and induced jobs, with annual total statewide labor income of ~$1.55 billion. The economic impact study, titled "The Economic Impact of Allergan on the California Economy," was conducted and developed by Dr. Wallace Walrod, Chief Economic Adviser, at the Orange County Business Council.

  • Benzinga19 hours ago

    The Drug Price Increase Debate: Separating The Winners From The Losers

    “Political pressure on drug pricing has reached the point where the ability of biopharma companies to adapt to a more restrained pricing environment will differentiate winners and losers, in our view,” ...

  • Market Realist21 hours ago

    This Strategy Could Boost Teva’s Growth Prospects Even More

    Excluding API sales, in 2016, Teva Pharmaceutical Industries is expected to earn about 50% of its net sales from the North American market.